CatalystCorporate
Revelation Biosciences announces 1-for-7 reverse stock split
1-for-7 reverse stock split signals potential delisting risk and share consolidation.
Context
What happened: Revelation Biosciences (REVB) announced a 1-for-7 reverse stock split, effective Oct. 20, with shares trading on a post-split basis from the start of trading that day.
Key numbers: 1-for-7 reverse split; effective Oct. 20.
Why it matters: The company said the reverse split is aimed at raising the per-share price. The supplied content does not state further details on the rationale or any analyst or market reaction.
Coverage: 3 outlets in 24h
What changed
Revelation Biosciences (REVB) announced a 1-for-7 reverse stock split, effective Oct. 20, with shares trading on a post-split basis from the start of trading that day.
Why it matters
The company said the reverse split is aimed at raising the per-share price. The supplied content does not state further details on the rationale or any analyst or market reaction.